Suppr超能文献

巨噬细胞作为肝细胞癌治疗的靶点。

Macrophages as Targets in Hepatocellular Carcinoma Therapy.

机构信息

Department of Hepatobiliary and Pancreatic Surgery, The Second Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, Zhejiang, China.

Key Laboratory of Precision Diagnosis and Treatment for Hepatobiliary and Pancreatic Tumor of Zhejiang Province, Hangzhou, Zhejiang, China.

出版信息

Mol Cancer Ther. 2024 Jun 4;23(6):780-790. doi: 10.1158/1535-7163.MCT-23-0660.

Abstract

Hepatocellular carcinoma (HCC) is a malignant tumor with a complex and diverse immunosuppressive microenvironment. Tumor-associated macrophages (TAM) are an essential component of the tumor immune microenvironment. TAMs typically exist in two primary states: anti-tumor M1 macrophages and protumor M2 macrophages. Remarkably, TAMs possess high plasticity, enabling them to switch between different subtypes or alter their biological functions in response to the tumor microenvironment. Based on research into the biological role of TAMs in the occurrence and development of malignant tumors, including HCC, TAMs are emerging as promising targets for novel tumor treatment strategies. In this review, we provide a detailed introduction to the origin and subtypes of TAMs, elucidate their interactions with other cells in the complex tumor microenvironment of HCC, and describe the biological roles, characteristics, and mechanisms of TAMs in the progression of HCC. Furthermore, we furnish an overview of the latest therapeutic strategies targeting TAMs.

摘要

肝细胞癌 (HCC) 是一种具有复杂和多样化免疫抑制微环境的恶性肿瘤。肿瘤相关巨噬细胞 (TAM) 是肿瘤免疫微环境的重要组成部分。TAM 通常存在两种主要状态:抗肿瘤 M1 巨噬细胞和促肿瘤 M2 巨噬细胞。值得注意的是,TAM 具有高度的可塑性,能够在不同亚型之间转换或根据肿瘤微环境改变其生物学功能。基于 TAM 在包括 HCC 在内的恶性肿瘤发生和发展中的生物学作用的研究,TAM 正在成为新的肿瘤治疗策略的有前途的靶点。在这篇综述中,我们详细介绍了 TAM 的起源和亚型,阐明了它们与 HCC 复杂肿瘤微环境中其他细胞的相互作用,并描述了 TAM 在 HCC 进展中的生物学作用、特征和机制。此外,我们概述了针对 TAM 的最新治疗策略。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验